ReviewHerzschrittmachertherapie & Elektrophysiologie2026
[Diagnostic and prognostic value of the resting ECG in structural heart disease].
Review in Herzschrittmachertherapie & Elektrophysiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 12-lead resting electrocardiogram (ECG) remains a central tool in the diagnosis and risk stratification of structural heart disease despite significant advances in cardiac imaging. This review highlights the role of the resting ECG in ischemic cardiomyopathy, hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), including its differentiation from cardiac sarcoidosis, as well as in genetically determined forms of dilated cardiomyopathy (DCM) and nondilated left ventricular cardiomyopathy (NDLVC). Characteristic electrocardiographic patterns not only facilitate identification of the underlying myocardial substrate but also provide prognostically relevant information regarding arrhythmic events and sudden cardiac death. Particularly in genetic cardiomyopathies, electrical abnormalities may precede overt structural manifestations, thereby enabling early phenotypic characterization. Despite the limited sensitivity of individual parameters, the resting ECG remains a widely available, cost-effective, and clinically highly relevant instrument that constitutes an integral component of contemporary guideline recommendations.
Indexed as
Identifiers
42455151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.